U.S. markets closed

Alfresa Holdings Corporation (ARHCF)

Other OTC - Other OTC Precio retrasado. Divisa en USD.
Añadir a la lista de seguimiento
11.87-1.82 (-13.29%)
Al cierre: 12:12PM EDT

Alfresa Holdings Corporation

1-1-3 Otemachi
Chiyoda-ku
Tokyo 100-0004
Japan
81 3 5219 5100
https://www.alfresa.com

Sector(es)Healthcare
IndustriaMedical Distribution
Empleados a tiempo completo

Ejecutivos clave

NombreTítuloPagarEjecutadoAño de nacimiento
Mr. Ryuji ArakawaPresident & Representative DirectorN/DN/D1963
Toshiki TanakaVP, Executive Officer of Gen Affairs, HR Planning, Digital Transformation (DX) and Compliance & DirN/DN/D1963
Mr. Seiichi KishidaExecutive VP, Assistant to the President & Representative DirectorN/DN/D1960
Mr. Yusuke FukujinExecutive VP & Representative DirectorN/DN/D1976
Shigeki OhashiVP, Exe. Officer of Grp Bus, Affiliate Control, Bus Dev & International Business and DirectorN/DN/D1965
Kazuaki HanoExecutive OfficerN/DN/DN/D
Soichi NemotoExecutive OfficerN/DN/DN/D
Toshikazu UrakabeExecutive OfficerN/DN/DN/D
Takashi SasakiExecutive OfficerN/DN/DN/D
Miki OguchiExecutive OfficerN/DN/DN/D
Los importes son a partir de y los valores de compensación son para el último año fiscal que finaliza en esa fecha. Pago corresponde al salario, las bonificaciones, etc. Ejecutado corresponde al valor de las opciones ejecutadas durante el año fiscal. Divisa en USD.

Descripción

Alfresa Holdings Corporation, through its subsidiaries, engages in the manufacture, wholesale, marketing, and import/export of pharmaceuticals, diagnostic reagents, and medical devices/equipment in Japan and internationally. It is involved in the ethical pharmaceuticals wholesaling business that offers diagnostic reagents and medical devices/equipment to hospitals, clinics, and dispensing pharmacies. The company also engages in self-medication products wholesaling business that offers over-the-counter drugs, including health foods, supplements, and other products to drug stores and pharmacies. In addition, it manufactures and markets active pharmaceutical ingredients, pharmaceuticals, diagnostic reagents, and medical devices, as well as undertakes contract manufacturing of pharmaceuticals. Further, the company's medical-related business includes its dispensing pharmacy and other medical-related businesses. The company was incorporated in 2003 and is based in Tokyo, Japan.

Gestión corporativa

La calificación ISS Governance QuickScore de Alfresa Holdings Corporation a partir del 1 de mayo de 2024 es 10. Las puntuaciones principales son Auditoría: 4; Junta: 9; Derechos del accionista: 8; Compensación: 6.

Las puntuaciones de la gestión corporativa son cortesía de Servicios de accionistas institucionales (ISS). Las puntuaciones indican una posición decil en relación con el índice o la región. Una puntuación decil 1 indica que el riesgo de gestión es menor, mientras que una puntuación decil 10 indica que el riesgo de gestión es mayor.